Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a low dose and a high dose of the study
drug SCA-136 are effective and safe in the treatment of schizophrenia requiring
hospitalization.